The $580,000 purchase order from a order from a top-tier academic medical center provides a key commercial reference, supporting Inspira's ongoing strategic process. Traders should watch for potential partnership, licensing, or monetization announcements related to the ART100 platform, which could unlock further value. With a market cap of only $2M, this order represents meaningful revenue relative to scale.
Price Chart
Executive Summary
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems, blood circulation systems. The order follows a multi-patient clinical evaluation at NYU Langone and is scheduled for immediate fulfillment.
Key Facts
- Inspira received a $580,000 purchase order from NYU Langone Hospital for the ART100 system.
- The order was placed through Inspira received follows a multi-patient clinical evaluation involving more than 30 patients.
- The ART100 system is FDA-cleared for cardiopulmonary bypass procedures.
- The systems are scheduled for immediate fulfillment.
- Inspira disclosed it is advancing an 'active strategic process' involving multiple counterparties regarding the ART100 platform and additional medical assets.
Financial Impact
$580,000 commercial purchase order from NYU Langone Hospital.
Risk Factors
- The order is a single, modest transaction that may not extrapolate to scale.
- The company is actively seeking to monetize ART100 and other medical assets—there is no guarantee of a favorable transaction.
- No financial details or profitability impact disclosed; historical 20-F shows pre-revenue stage.
- Warrant ticker IINNW is highly speculative, volatile and prone to large price swings irrespective of news quality.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001185185-26-001890 |
| Document: iinnex99-1.htm | 0001185185-26-001890 |
| Document: 0001185185-26-001890-index-headers.html | 0001185185-26-001890 |
| Document: 0001185185-26-001890-index.html | 0001185185-26-001890 |
| Document: 0001185185-26-001890.txt | 0001185185-26-001890 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 19, 2026 19w ago | 6-K | $0.1420 $0.1200 | ▼ −15.49% | ▼ −16.48% | — |
May 18, 2026 19w ago | 6-K | $0.0830 $0.1310 | ▲ +57.83% | ▲ +56.25% | — |
Apr 16, 2026 24w ago | 6-K | $0.1100 $0.0690 | ▼ −37.27% | ▼ −43.09% | — |
Apr 16, 2026 24w ago | 6-K | $0.1100 $0.0690 | ▼ −37.27% | ▼ −43.09% | — |
Apr 15, 2026 24w ago | 6-K | $0.1100 $0.0690 | ▼ −37.27% | ▼ −43.09% | — |
Apr 14, 2026 24w ago | 6-K | $0.0720 $0.0690 | ▼ −4.17% | ▼ −10.46% | — |
Apr 13, 2026 24w ago | 6-K | $0.0600 $0.0690 | ▲ +15.00% | ▲ +7.27% | — |
Apr 6, 2026 25w ago | 6-K | $0.1000 $0.0680 | ▼ −32.00% | ▼ −40.98% | — |
Apr 6, 2026 25w ago | 6-K | $0.1000 $0.0680 | ▼ −32.00% | ▼ −40.98% | — |
Mar 31, 2026 26w ago | 6-K | $0.0800 $0.0690 | ▼ −13.75% | ▼ −23.17% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access